Correlation Between Aileron Therapeutics and SAB Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Aileron Therapeutics and SAB Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aileron Therapeutics and SAB Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aileron Therapeutics and SAB Biotherapeutics, you can compare the effects of market volatilities on Aileron Therapeutics and SAB Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aileron Therapeutics with a short position of SAB Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aileron Therapeutics and SAB Biotherapeutics.
Diversification Opportunities for Aileron Therapeutics and SAB Biotherapeutics
0.28 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Aileron and SAB is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Aileron Therapeutics and SAB Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SAB Biotherapeutics and Aileron Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aileron Therapeutics are associated (or correlated) with SAB Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SAB Biotherapeutics has no effect on the direction of Aileron Therapeutics i.e., Aileron Therapeutics and SAB Biotherapeutics go up and down completely randomly.
Pair Corralation between Aileron Therapeutics and SAB Biotherapeutics
Given the investment horizon of 90 days Aileron Therapeutics is expected to under-perform the SAB Biotherapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Aileron Therapeutics is 1.77 times less risky than SAB Biotherapeutics. The stock trades about -0.39 of its potential returns per unit of risk. The SAB Biotherapeutics is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 292.00 in SAB Biotherapeutics on August 29, 2024 and sell it today you would earn a total of 5.00 from holding SAB Biotherapeutics or generate 1.71% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Aileron Therapeutics vs. SAB Biotherapeutics
Performance |
| Timeline |
| Aileron Therapeutics |
| SAB Biotherapeutics |
Aileron Therapeutics and SAB Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aileron Therapeutics and SAB Biotherapeutics
The main advantage of trading using opposite Aileron Therapeutics and SAB Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aileron Therapeutics position performs unexpectedly, SAB Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SAB Biotherapeutics will offset losses from the drop in SAB Biotherapeutics' long position.| Aileron Therapeutics vs. Bright Minds Biosciences | Aileron Therapeutics vs. HP Inc | Aileron Therapeutics vs. Intel | Aileron Therapeutics vs. Chevron Corp |
| SAB Biotherapeutics vs. Processa Pharmaceuticals | SAB Biotherapeutics vs. Third Harmonic Bio | SAB Biotherapeutics vs. Cingulate Warrants | SAB Biotherapeutics vs. Anebulo Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |